-
1h 2m 8sPart 2 | Session 8 Plenary session 10 – Special Populations
-
1h 54sPart 1 | Session 1 Plenary session 1 – Recent guideline updates in HF
-
1h 8m 32sPart 1 | Session 3 Plenary session 2 – GDMT in the clinical setting
-
51m 41sPart 1 | Session 4 Special Live Interactive Session – Management of ATTR-CM
-
57m 43sPart 1 | Session 6 Plenary session 3 – SGLT2i in clinical practice
-
1h 1m 49sPart 1 | Session 8 Plenary session 4 – Obesity and weight management in HF
-
56m 50sPart 1 | Session 10 Plenary session 5 – Worsening and acute heart failure
-
1h 1m 56sPart 2 | Session 2 Plenary session 6 – Iron deficiency: the totality of evidence
-
59m 4sPart 2 | Session 4 Plenary session 7 – Managing comorbidities in HF
-
1h 46sPart 2 | Session 5 Plenary session 8 – Devices in HF: time to reassess their place?
Translational Medicine Academy (TMA) in partnership with Radcliffe Cardiology were delighted to announce the return of e-SPACE Heart Failure 2023.
A thoughtfully curated programme supported the exploration of how leading experts are implementing the new heart failure guidelines into clinical practice and showed the latest information on patient profiling in heart failure for tailoring medical therapy.
This event once again brought together TMA’s mandate for the delivery of continuing professional development to healthcare professionals to achieve concordance with appropriate treatment plans, with Radcliffe Cardiology’s goal to deliver cardiovascular knowledge to best support cardiovascular communities transform theory into practice.
Learning Objectives
- Review the burden of heart failure with reduced ejection fraction (HFrEF) and heart failure with preserved ejection fraction (HFpEF) as one of the leading causes of disability and mortality worldwide
- Understand the latest guideline recommendations and discuss their applicability according to patients phenotypes
- Discuss the implementation in clinical practice of the four foundational therapies and additional drugs and devices to improve patient outcomes
- Develop a comprehensive understanding of best practices for the screening, diagnosis and management of the patient with heart failure and comorbidities
- Translate the findings of recent studies and guidelines into optimal patient management
Target Audience
- Heart Failure Specialists
- General Cardiologists
- General Practitioners (GPs)
- Nurses, Pharmacists, and other Allied Healthcare Professionals
More from this programme
Faculty Biographies
John GF Cleland
Professor of Cardiology
Prof John Cleland is a Professor of Cardiology at University of Glasgow, Glasgow, UK.
In 1977, he qualified from the University of Glasgow, completed training at St. Mary's & Hammersmith Hospitals (London) and was awarded a Senior Fellowship by the British Heart Foundation.
His main interests include heart failure, extending from epidemiology & prevention, to Phase II-IV trials and guidelines.
He founded the European Journal of Heart Failure and is Past-Chair of the ESC Working Group on heart failure and British Society for Heart Failure.
Lynne W Stevenson
Professor of Medicine and Director of Cardiomyopathy Program
Dr Lynne Stevenson is a Professor of Medicine and Director of Cardiomyopathy Program at Vanderbilt University Medical Center, Nashville, US.
Her research experience includes acute and ambulatory hemodynamic monitoring, exercise physiology, heart failure hospitalisations and the interface of arrhythmias and sudden death risk with left ventricular dysfunction.
Jasper J Brugts
Heart Failure Cardiologist
Dr Jasper J Brugts is a Heart Failure Cardiologist at Erasmus University Medical Centre, Rotterdam, NL.
He is also a clinical epidemiologist and clinical trialist.
Dan Burkhoff
Director
Dr Dan Burkhoff is currently the Director of Heart Failure, Hemodynamics and MCS Research at Cardiovascular Research Foundation, New York, US. Dr Burkhoff's interest include cardiovascular modeling and ventricular mechanics, cardiovascular monitoring, heart failure, device and pharmacologic treatments for heart failure, including left ventricular assist devices. He is also author of Harvi, an interactive simulation-based application for teaching and researching on ventricular mechanics and hemodynamics.
Comments